Franzoni E, Matricardi S, Di Pisa V, Capovilla G, Romeo A, Tozzi E, Pruna D, Salerno GG, Zamponi N, Accorsi P et al: Refractory absence seizures: An Italian multicenter retrospective study. Eur J Paediatr Neurol 2015, 19(6):660-664.

Kessler SK, McGinnis E: A Practical Guide to Treatment of Childhood Absence Epilepsy. Paediatr Drugs 2019, 21(1):15-24.

Höfler J, Trinka E: Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013, 54(3):393-404.

Höfler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E: Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011, 52(10):e148-152.

Zawar I, Franic L, Knight EP: Response to lacosamide monotherapy in a patient with medically refractory Jeavons syndrome: a case report and review of the literature. Epileptic Disord 2020, 22(5):643-647.

Papacostas SS: Status epilepticus developing during lacosamide monotherapy. BMJ Case Rep 2015, 2015.

Ben-Menachem E, Grebe HP, Terada K, Jensen L, Li T, De Backer M, Steiniger-Brach B, Gasalla T, Brock M, Biton V: Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy. Epilepsia 2019, 60(12):2437-2447.

Catterall WA, Swanson TM: Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels. Mol Pharmacol 2015, 88(1):141-150.

Vossler DG, Knake S, O'Brien TJ, Watanabe M, Brock M, Steiniger-Brach B, Williams P, Roebling R: Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial. J Neurol Neurosurg Psychiatry 2020, 91(10):1067-1075.

Ákos Szabó C, Morgan LC, Sonnenberg S, Karkar KM: Absence status induced by lacosamide adjunctive therapy. Epileptic Disord 2019, 21(1):97-101.

Li J, Sun M, Wang X: The adverse-effect profile of lacosamide. Expert Opin Drug Saf 2020, 19(2):131-138.

Lancman ME, Fertig EJ, Trobliger RW, Perrine K, Myers L, Iyengar SS, Malik M: The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy. Epilepsy Behav 2016, 61:27-33.